Viracept and Peritonitis bacterial - a phase IV clinical study of FDA data


Peritonitis bacterial is found among people who take Viracept, especially for people who are male, 40-49 old, have been taking the drug for 2 - 5 years.

The phase IV clinical study analyzes which people take Viracept and have Peritonitis bacterial. It is created by eHealthMe based on reports of 6,187 people who have side effects when taking Viracept from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

6,187 people reported to have side effects when taking Viracept.
Among them, 9 people (0.15%) have Peritonitis bacterial.

What is Viracept?

Viracept has active ingredients of nelfinavir mesylate. It is often used in hiv infection. eHealthMe is studying from 6,194 Viracept users for its effectiveness, alternative drugs and more.

What is Peritonitis bacterial?

Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial) is found to be associated with 812 drugs and 469 conditions by eHealthMe.

Number of Viracept and Peritonitis bacterial reports submitted per year:

Could Viracept cause Peritonitis bacterial?

Time on Viracept when people have Peritonitis bacterial *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 100 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Peritonitis bacterial when taking Viracept *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Peritonitis bacterial when taking Viracept *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 11.11 %
  • 40-49: 88.89 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Viracept *:

  1. Atenolol: 6 people, 66.67%
  2. Combivir: 6 people, 66.67%
  3. Duphalac: 6 people, 66.67%
  4. Aldactone: 5 people, 55.56%
  5. Oxazepam: 3 people, 33.33%
  6. Vitamin B6: 2 people, 22.22%
  7. Folic Acid: 1 person, 11.11%
  8. Bactrim: 1 person, 11.11%
  9. Epivir: 1 person, 11.11%
  10. Ziagen: 1 person, 11.11%

Common side effects people have besides Peritonitis bacterial *:

  1. Ventricular Extrasystoles (premature cardiac contraction): 7 people, 77.78%
  2. Torsade De Pointes (a abnormal heart rate with abnormal beating pattern): 7 people, 77.78%
  3. Splenomegaly (enlargement of spleen): 7 people, 77.78%
  4. Joint Pain: 7 people, 77.78%
  5. Fainting (loss of consciousness and postural tone): 6 people, 66.67%
  6. Ascites (accumulation of fluid in the abdominal cavity): 6 people, 66.67%
  7. Weight Increased: 5 people, 55.56%
  8. Electrocardiogram Qt Prolonged: 5 people, 55.56%
  9. Loss Of Consciousness: 5 people, 55.56%
  10. Gastric Ulcer (stomach ulcer): 5 people, 55.56%

Common conditions people have *:

  1. Polysubstance Dependence: 2 people, 22.22%
  2. Insomnia (sleeplessness): 2 people, 22.22%
  3. Ill-Defined Disorder: 2 people, 22.22%

* Approximation only. Some reports may have incomplete information.

Do you take Viracept and have Peritonitis bacterial?

Check whether Peritonitis bacterial is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Peritonitis bacterial and when was it recovered:

Expand to all the drugs that have ingredients of nelfinavir mesylate:

Alternative drugs to, pros and cons of Viracept:

Common Viracept side effects:

Browse all side effects of Viracept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Peritonitis bacterial treatments and more:

COVID vaccines that are related to Peritonitis bacterial:

Common drugs associated with Peritonitis bacterial:

All the drugs that are associated with Peritonitis bacterial:

Common conditions associated with Peritonitis bacterial:

All the conditions that are associated with Peritonitis bacterial:

How the study uses the data?

The study uses data from the FDA. It is based on nelfinavir mesylate (the active ingredients of Viracept) and Viracept (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: